Combinatorial glucose, nicotinic acid and N-acetylcysteine therapy has synergistic effect in preclinical C
Remember, ignorance of this rule wont excuse the consequences

Ovarian cancer is the sixth most common malignancy among women in developed countries and the fifth leading cause of cancer-related death, representing a complex disease associated with poor survival rates.24 The combination chemotherapy of Paclitaxel (PTX) and Carboplatin (CARB) is considered the first-line treatment regimen for ovarian cancer.25 Both agents play distinct roles in inhibiting the growth of ovarian cancer through different mechanisms,26 and they are known to exert a synergistic anti-tumor effect by activating separate apoptotic signaling pathways, thereby potentially reducing drug resistance.25 The gonadotoxic effects of platinum-based chemotherapeutic agents have been demonstrated in numerous studies, both histopathologically and in terms of follicular development.27-29 In the present study, CARB administration led to significant histopathological damage in ovarian tissue, including follicular degeneration, prominent stromal edema, congestion, hemorrhage, inflammation, and fibrosis, particularly in the medullary region

Convenient, though systemic exposure is lower than injectable
View Details MegaMucosa 180 Capsules The first complete mucosal support supplement of its kind, formulated to support a healthy mucosal barrier View Details MegaMucosa Powder The first complete mucosal support supplement of its kind, formulated to support a healthy mucosal barrier View Details MegaMucosa Stick Packs Mucosal Support Supplement Stick Packs formulated to support a healthy mucosal barrier View Details MegaPre 180 Capsules The first Precision Prebiotic supplement made up of clinically tested, non-digestible oligosaccharides View Details